Spots Global Cancer Trial Database for anaplastic glioma
Every month we try and update this database with for anaplastic glioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab | NCT01743950 | Glioma | Bevacizumab PRDR | 18 Years - | University of Wisconsin, Madison | |
| Natural History of Patients With Brain and Spinal Cord Tumors | NCT00009035 | Astrocytoma Oligodendroglio... Glioblastoma Glioma Anaplastic Glio... | 1 Year - 100 Years | National Institutes of Health Clinical Center (CC) | ||
| A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab | NCT01743950 | Glioma | Bevacizumab PRDR | 18 Years - | University of Wisconsin, Madison | |
| Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma | NCT00613093 | Glioblastoma Mu... Anaplastic Glio... | Temodar and O6-... | 18 Years - | Duke University | |
| HYPONCO - Hypoxia in Brain Tumors | NCT01200134 | Anaplastic Glio... | 18F-FMISO PET-s... | 18 Years - | University Hospital, Caen | |
| 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients | NCT00504660 | Anaplastic Glio... Glioblastoma Mu... Brain Cancer | Capecitabine Celecoxib (Cele... Temozolomide Lomustine 6-Thioguanine | 12 Years - | M.D. Anderson Cancer Center | |
| A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma | NCT00389090 | Glioma Astrocytoma Oligodendroglio... Oligoastrocytom... | Temozolomide an... | 18 Years - | Keryx / AOI Pharmaceuticals, Inc. | |
| Antineoplaston Therapy in Treating Children With Brain Tumors | NCT00003458 | Childhood Brain... | Antineoplaston ... | 6 Months - 18 Years | Burzynski Research Institute | |
| A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas | NCT00704080 | Mixed Gliomas Malignant Gliom... Glioblastoma Mu... | XL765 (SAR24540... Temozolomide | 18 Years - | Sanofi | |
| HYPONCO - Hypoxia in Brain Tumors | NCT01200134 | Anaplastic Glio... | 18F-FMISO PET-s... | 18 Years - | University Hospital, Caen | |
| A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab | NCT01743950 | Glioma | Bevacizumab PRDR | 18 Years - | University of Wisconsin, Madison | |
| Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme | NCT03363659 | Glioblastoma Glioblastoma Mu... | Disulfiram Copper gluconat... Temozolomide | 18 Years - | Aurora Health Care | |
| Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM) | NCT00555399 | Glioblastoma Mu... Anaplastic Glio... | Vorinostat Isotretinoin Surgical Resect... Temozolomide | 18 Years - | M.D. Anderson Cancer Center | |
| Natural History of Patients With Brain and Spinal Cord Tumors | NCT00009035 | Astrocytoma Oligodendroglio... Glioblastoma Glioma Anaplastic Glio... | 1 Year - 100 Years | National Institutes of Health Clinical Center (CC) | ||
| First in Patient Study for PF-06840003 in Malignant Gliomas | NCT02764151 | Oligodendroglio... Astrocytoma Malignant Gliom... | PF-06840003 | 18 Years - | Pfizer | |
| Re-irradiation of High Grade Gliomas: a Quality of Life Study | NCT01711580 | Anaplastic Astr... Glioblastoma Mu... Anaplastic Olig... | EORTC QLQ-C30 EORTC QLQ-BN20 Hopkins Verbal ... Stroop color-wo... Controlled oral... Jamar hand dyna... EORTC QLQ- FA13 Trail Making Te... | 18 Years - | Maastricht Radiation Oncology | |
| Antineoplaston Therapy in Treating Children With Brain Tumors | NCT00003458 | Childhood Brain... | Antineoplaston ... | 6 Months - 18 Years | Burzynski Research Institute | |
| A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma | NCT00389090 | Glioma Astrocytoma Oligodendroglio... Oligoastrocytom... | Temozolomide an... | 18 Years - | Keryx / AOI Pharmaceuticals, Inc. | |
| Re-irradiation of High Grade Gliomas: a Quality of Life Study | NCT01711580 | Anaplastic Astr... Glioblastoma Mu... Anaplastic Olig... | EORTC QLQ-C30 EORTC QLQ-BN20 Hopkins Verbal ... Stroop color-wo... Controlled oral... Jamar hand dyna... EORTC QLQ- FA13 Trail Making Te... | 18 Years - | Maastricht Radiation Oncology |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
